KMTS Kestra Medical Technologies, Ltd. - Common Stock
$20,00
Fiyat · May 20, 2026
Temel veriler itibarıyla Mar 17, 2026
52 Haftlık Aralık
$13–$30
40% of range
Analist Derecelendirmesi
STRONG BUY
13 analysts
Fiyat Hedefi
$28
+39% upside
P/E (TTM)
-4.7
ROE
433.7%
Net Kâr Marjı
-190.3%
KMTS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$20.00
Piyasa Değeri
$1.24B
P/E (TTM)
-4.7
EPS (TTM)
$-5.13
Gelir (TTM)
$60M
Temettü Verimi
—
ROE
433.7%
D/E Borç/Özsermaye
0.2
52 Haftlık Aralık
$13 – $30
KMTS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$60M
2024-04-30
→
2025-04-30
Hisse Başına Kâr
$-5.13
2024-04-30
→
2025-04-30
Serbest Nakit Akışı
$-101M
2025-04-30
→
2025-04-30
Marjlar
-190.3%
2025-04-30
→
2025-04-30
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
KMTS
Akran Ortalaması
P/E (TTM)
-4.7
58.4
P/S (TTM) (F/S (TTM))
20.7
4.2
P/B (F/D)
6.0
4.1
EV / EBITDA
-10.6
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-12.3
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
KMTS
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
40.5%
66.4%
Operating Margin (Faaliyet Kâr Marjı)
-177.8%
—
Net Profit Margin (Net Kâr Marjı)
-190.3%
-1.7%
ROA
-66.6%
-1.8%
ROE
433.7%
-1.9%
ROIC
-43.2%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
KMTS
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.2
19.9
Current Ratio (Cari Oran)
6.7
4.4
Quick Ratio (Cari Oran)
6.5
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
KMTS
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
115.1%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
KMTS
Akran Ortalaması
KMTS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 6 46,2%
- Al 5 38,5%
- Tut 2 15,4%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
7 analist · 2026-05-17
Medyan
$30.00
Ortalama
$27.71
Şimdi
$20.00
Düşük
$17.00
Yüksek
$30.00
Medyan hedef
$30.00
+50,0%
Ortalama hedef
$27.71
+38,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.35%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.61 | $-0.61 | -0.00% |
| 31 Aralık 2025 | $-0.64 | $-0.60 | -0.04% |
| 30 Eylül 2025 | $-0.45 | $-0.77 | 0.32% |
| 30 Haziran 2025 | $-2.21 | $-0.54 | -1.7% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KMTS | $1.24B | -4.7 | 115.1% | -190.3% | 433.7% | 40.5% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| ATRC | $1.97B | -164.8 | 14.9% | -2.1% | -2.4% | 75.0% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| INSP | $2.64B | 18.9 | 13.6% | 16.0% | 19.9% | 85.4% |
| ASST | — | -0.1 | 1217.5% | — | — | — |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| BFLY | — | -12.3 | 19.0% | -79.0% | -35.9% | 46.9% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue | $60M | $28M | |
| Cost of Revenue | $36M | $27M | |
| Gross Profit | $24M | $362.0K | |
| R&D Expense | $16M | $15M | |
| SG&A Expense | $115M | $70M | |
| Operating Expenses | $131M | $85M | |
| Operating Income | $-106M | $-85M | |
| Interest Income | $3M | · | |
| Other Non-op | $-3M | $-3M | |
| Pretax Income | $-114M | $-94M | |
| Income Tax | $135.0K | $24.0K | |
| Net Income | $-114M | $-94M | |
| EPS (Basic) | $-5.13 | $-5.07 | |
| EPS (Diluted) | $-5.13 | $-5.07 | |
| Shares (Basic) | 24,583,745 | 19,885,382 | |
| Shares (Diluted) | 24,583,745 | 19,885,382 | |
| EBITDA | $-98M | · |
Bilanço 22
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $238M | $8M | |
| Receivables | $8M | $2M | |
| Prepaid Expense | $3M | $1M | |
| Other Current Assets | $2M | $419.0K | |
| Current Assets | $255M | $15M | |
| PP&E (Net) | $35M | $26M | |
| PP&E (Gross) | $59M | $44M | |
| Accum. Depreciation | $24M | $18M | |
| Other Non-current Assets | $1M | $607.0K | |
| Total Assets | $296M | $46M | |
| Accounts Payable | $24M | $24M | |
| Accrued Liabilities | $14M | $9M | |
| Current Liabilities | $38M | $33M | |
| Capital Leases | $3M | $3M | |
| Other Non-current Liabilities | $140.0K | $76.0K | |
| Total Liabilities | $90M | $78M | |
| Total Debt | $41M | · | |
| Common Stock | $51M | $20M | |
| Retained Earnings | $-520M | $-406M | |
| Stockholders' Equity | $205M | $-209M | |
| Liabilities + Equity | $296M | $46M | |
| Shares Outstanding | 51,348,656 | 105,808 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| D&A | $8M | $12M | |
| Stock-based Comp | $24M | $1M | |
| Deferred Tax | $64.0K | $12.0K | |
| Other Non-cash | $4M | · | |
| Operating Cash Flow | $-78M | $-72M | |
| CapEx | $23M | $12M | |
| Investing Cash Flow | $-23M | $-12M | |
| Debt Issued | · | $45M | |
| Stock Issued | $216M | · | |
| Net Stock Activity | $216M | · | |
| Financing Cash Flow | $330M | $78M | |
| Net Change in Cash | $229M | $-7M | |
| Taxes Paid | $83.0K | $-30.0K | |
| Free Cash Flow | $-101M | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 40.5% | · | |
| Operating Margin | -177.8% | · | |
| Net Margin | -190.3% | · | |
| Pretax Margin | -190.1% | · | |
| EBITDA Margin | -164.5% | · | |
| ROA | -66.6% | · | |
| ROE | 433.7% | · | |
| ROIC | -43.2% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 6.7 | · | |
| Quick Ratio | 6.5 | · | |
| Debt / Equity | 0.2 | · | |
| LT Debt / Equity | 0.2 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.4 | · | |
| Receivables Turnover | 11.9 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 115.1% | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $60M | · | |
| Net Income TTM | $-114M | · | |
| Market Cap | $1.24B | · | |
| Enterprise Value | $1.04B | · | |
| P/E | -4.7 | · | |
| P/S | 20.7 | · | |
| P/B | 6.0 | · | |
| P / Tangible Book | 6.0 | · | |
| P / Cash Flow | -15.9 | · | |
| P / FCF | -12.3 | · | |
| EV / EBITDA | -10.6 | · | |
| EV / FCF | -10.3 | · | |
| EV / Revenue | 17.4 | · | |
| Earnings Yield | -21.3% | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25M | $23M | $19M | $17M | $15M | $15M | $13M | |
| Cost of Revenue | $12M | $11M | $11M | $10M | $9M | $9M | $9M | |
| Gross Profit | $13M | $11M | $9M | $8M | $7M | $6M | $4M | |
| R&D Expense | $5M | $5M | $4M | $5M | $3M | $4M | $3M | |
| SG&A Expense | $43M | $38M | $34M | $50M | $24M | $21M | $19M | |
| Operating Expenses | $48M | $43M | $38M | $56M | $27M | $25M | $23M | |
| Operating Income | $-35M | $-32M | $-29M | $-48M | $-21M | $-19M | $-18M | |
| Interest Income | $2M | $2M | $2M | $2M | $628.0K | $878.0K | $37.0K | |
| Other Non-op | $359.0K | $-891.0K | $3M | $-3M | $15.0K | $-40.0K | $-48.0K | |
| Pretax Income | $-34M | $-33M | $-26M | $-51M | $-22M | $-21M | $-20M | |
| Income Tax | $35.0K | $34.0K | $33.0K | $102.0K | $18.0K | $8.0K | $7.0K | |
| Net Income | $-34M | $-33M | $-26M | $-52M | $-22M | $-20M | $-20M | |
| EPS (Basic) | $-0.61 | $-0.64 | $-0.50 | $-1.57 | $-1.25 | $-1.19 | $-1.12 | |
| EPS (Diluted) | $-0.61 | $-0.64 | $-0.50 | $-1.57 | $-1.25 | $-1.19 | $-1.12 | |
| Shares (Basic) | 55,848,413 | 51,376,278 | 51,304,599 | -35,072,401 | 19,885,382 | 19,885,382 | 19,885,382 | |
| Shares (Diluted) | 55,848,413 | 51,376,278 | 51,304,599 | -35,072,401 | 19,885,382 | 19,885,382 | 19,885,382 | |
| EBITDA | $-35M | $-32M | $-27M | · | · | · | · |
Bilanço 22
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $291M | $175M | $201M | $238M | · | · | · | |
| Receivables | $13M | $10M | $9M | $8M | · | · | · | |
| Prepaid Expense | $3M | $3M | $3M | $3M | · | · | · | |
| Other Current Assets | $1M | $1M | $2M | $2M | · | · | · | |
| Current Assets | $314M | $195M | $221M | $255M | · | · | · | |
| PP&E (Net) | $54M | $46M | $40M | $35M | · | · | · | |
| PP&E (Gross) | $83M | $74M | $66M | $59M | · | · | · | |
| Accum. Depreciation | $29M | $28M | $26M | $24M | · | · | · | |
| Other Non-current Assets | $6M | $1M | $1M | $1M | · | · | · | |
| Total Assets | $379M | $247M | $266M | $296M | · | · | · | |
| Accounts Payable | $24M | $20M | $19M | $24M | · | · | · | |
| Accrued Liabilities | $19M | $15M | $14M | $14M | · | · | · | |
| Current Liabilities | $43M | $36M | $32M | $38M | · | · | · | |
| Capital Leases | $4M | $3M | $3M | $3M | · | · | · | |
| Other Non-current Liabilities | $140.0K | $140.0K | $140.0K | $140.0K | · | · | · | |
| Total Liabilities | $91M | $83M | $82M | $90M | · | · | · | |
| Total Debt | $42M | $42M | $41M | · | · | · | · | |
| Common Stock | $58M | $51M | $51M | $51M | $100 | · | · | |
| Retained Earnings | $-613M | $-579M | $-546M | $-520M | · | · | · | |
| Stockholders' Equity | $288M | $164M | $184M | $205M | · | · | · | |
| Liabilities + Equity | $379M | $247M | $266M | $296M | · | · | · | |
| Shares Outstanding | 58,349,053 | 51,449,053 | 51,348,656 | 51,348,656 | 100 | · | · |
Nakit Akışı 10
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $10M | $9M | $5M | $22M | $459.0K | $1M | $377.0K | |
| Other Non-cash | · | · | $-7M | · | · | · | · | |
| Operating Cash Flow | $-18M | $-18M | $-26M | $-24M | $-18M | $-18M | $-17M | |
| CapEx | $10M | $7M | $8M | $7M | $4M | $4M | $7M | |
| Investing Cash Flow | $-15M | $-7M | $-8M | $-7M | $-4M | $-4M | $-7M | |
| Financing Cash Flow | $149M | $-27.0K | $-2M | $215M | $-119.0K | $-575.0K | $116M | |
| Net Change in Cash | $116M | $-26M | $-36M | $183M | $-23M | $-23M | $92M | |
| Taxes Paid | $25.0K | $21.0K | $-39.0K | $2.0K | $38.0K | · | · | |
| Free Cash Flow | · | · | $-34M | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.6% | 50.6% | 45.7% | · | · | · | · | |
| Operating Margin | -141.6% | -140.7% | -149.1% | · | · | · | · | |
| Net Margin | -139.2% | -145.3% | -133.3% | · | · | · | · | |
| Pretax Margin | -139.0% | -145.1% | -133.1% | · | · | · | · | |
| EBITDA Margin | -141.6% | -140.7% | -138.6% | · | · | · | · | |
| ROA | -18.0% | -26.6% | -19.4% | · | · | · | · | |
| ROE | -23.7% | -40.0% | -28.1% | · | · | · | · | |
| ROIC | -10.5% | -15.4% | -12.8% | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 5.5 | 6.8 | · | · | · | · | |
| Quick Ratio | 7.1 | 5.2 | 6.5 | · | · | · | · | |
| Debt / Equity | 0.1 | 0.3 | 0.2 | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.3 | 0.2 | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.1 | · | · | · | · | |
| Receivables Turnover | 3.9 | 4.3 | 4.2 | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $82M | $72M | $62M | · | · | · | · | |
| Net Income TTM | $-114M | $-100M | $-88M | · | · | · | · | |
| Market Cap | $1.44B | $1.41B | $847M | · | · | · | · | |
| Enterprise Value | $1.19B | $1.28B | $688M | · | · | · | · | |
| P/E | -8.2 | -7.6 | -4.1 | · | · | · | · | |
| P/S | 17.6 | 19.6 | 13.7 | · | · | · | · | |
| P/B | 5.0 | 8.6 | 4.6 | · | · | · | · | |
| P / Tangible Book | 5.0 | 8.6 | 4.6 | · | · | · | · | |
| P / Cash Flow | · | · | -32.2 | · | · | · | · | |
| P / FCF | · | · | -24.6 | · | · | · | · | |
| EV / EBITDA | -34.2 | -40.2 | -25.6 | · | · | · | · | |
| EV / FCF | · | · | -20.0 | · | · | · | · | |
| EV / Revenue | 14.6 | 17.8 | 11.1 | · | · | · | · | |
| Earnings Yield | -12.2% | -13.1% | -24.6% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-04-30 | 2024-04-30 | |
|---|---|---|
| Gelir | $60M | $28M |
| Brüt Kâr Marjı % | 40.5% | — |
| Faaliyet Kâr Marjı % | -177.8% | — |
| Net Gelir | $-114M | $-94M |
| Seyreltilmiş Hisse Başı Kâr | $-5.13 | $-5.07 |
Bilanço
| 2025-04-30 | 2024-04-30 | |
|---|---|---|
| Borç / Öz Sermaye | 0.2 | — |
| Cari Oran | 6.7 | — |
| Cari Oran | 6.5 | — |
Nakit Akışı
| 2025-04-30 | 2024-04-30 | |
|---|---|---|
| Serbest Nakit Akışı | $-101M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.